[go: up one dir, main page]

NO20022976D0 - 2-(1H-indol-3yl)-2-okso-acetamider med antitumoraktivitet - Google Patents

2-(1H-indol-3yl)-2-okso-acetamider med antitumoraktivitet

Info

Publication number
NO20022976D0
NO20022976D0 NO20022976A NO20022976A NO20022976D0 NO 20022976 D0 NO20022976 D0 NO 20022976D0 NO 20022976 A NO20022976 A NO 20022976A NO 20022976 A NO20022976 A NO 20022976A NO 20022976 D0 NO20022976 D0 NO 20022976D0
Authority
NO
Norway
Prior art keywords
indol
antitumor activity
oxoacetamides
acetamides
colon
Prior art date
Application number
NO20022976A
Other languages
English (en)
Other versions
NO323312B1 (no
NO20022976L (no
Inventor
Ernesto Menta
Nicoletta Pescalli
Original Assignee
Novuspharma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novuspharma Spa filed Critical Novuspharma Spa
Publication of NO20022976D0 publication Critical patent/NO20022976D0/no
Publication of NO20022976L publication Critical patent/NO20022976L/no
Publication of NO323312B1 publication Critical patent/NO323312B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20022976A 1999-12-23 2002-06-20 2-(1H-indol-3yl)-2-okso-acetamider, sammensetninger inneholdende disse og deres anvendelse NO323312B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002693A IT1315267B1 (it) 1999-12-23 1999-12-23 Derivati di 2-(1h-indol-3-il)-2-oxo-acetammidi ad attivita'antitumorale
PCT/EP2000/013068 WO2001047916A1 (en) 1999-12-23 2000-12-21 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity

Publications (3)

Publication Number Publication Date
NO20022976D0 true NO20022976D0 (no) 2002-06-20
NO20022976L NO20022976L (no) 2002-06-20
NO323312B1 NO323312B1 (no) 2007-03-12

Family

ID=11384182

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022976A NO323312B1 (no) 1999-12-23 2002-06-20 2-(1H-indol-3yl)-2-okso-acetamider, sammensetninger inneholdende disse og deres anvendelse

Country Status (24)

Country Link
US (1) US6753342B2 (no)
EP (1) EP1244652B1 (no)
JP (1) JP2003519140A (no)
KR (1) KR100795533B1 (no)
CN (1) CN1250542C (no)
AT (1) ATE302772T1 (no)
AU (1) AU776332B2 (no)
BR (1) BR0016553A (no)
CA (1) CA2395205A1 (no)
CZ (1) CZ20022170A3 (no)
DE (1) DE60022227T2 (no)
EA (1) EA004925B1 (no)
ES (1) ES2246918T3 (no)
HU (1) HUP0203524A3 (no)
IL (2) IL150329A0 (no)
IT (1) IT1315267B1 (no)
MX (1) MXPA02006217A (no)
NO (1) NO323312B1 (no)
NZ (1) NZ519689A (no)
PL (1) PL356541A1 (no)
SK (1) SK285682B6 (no)
TR (1) TR200201613T2 (no)
WO (1) WO2001047916A1 (no)
ZA (1) ZA200204964B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE330955T1 (de) 1998-04-28 2006-07-15 Elbion Ag Indolderivate und deren verwendung als inhibitoren der phosphodiesterase 4.
IT1318641B1 (it) * 2000-07-25 2003-08-27 Novuspharma Spa Ammidi di acidi 2-(1h-indol-3-il)-2-oxo-acetici ad attivita'antitumorale.
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
CN101602756B (zh) * 2002-07-09 2014-11-12 法斯根公司 化合物、含该化合物的药物组合物以及该化合物的应用方法
BRPI0414313A (pt) 2003-09-11 2006-11-07 Kemia Inc inibidores de citocinas
WO2005094816A1 (en) * 2004-03-11 2005-10-13 Actelion Pharmaceuticals Ltd Indol-1-yl-acetic acid derivatives
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
US10022352B2 (en) 2006-04-07 2018-07-17 Vertex Pharmaceuticals Incorporated Modulators of ATP-binding cassette transporters
SI2007756T1 (sl) 2006-04-07 2015-11-30 Vertex Pharmaceuticals Incorporated Modulatorji prenašalcev z atp-vezavno kaseto
USRE50453E1 (en) 2006-04-07 2025-06-10 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
EP2049520A4 (en) * 2006-08-07 2011-01-05 Ironwood Pharmaceuticals Inc indole compounds
US8563573B2 (en) 2007-11-02 2013-10-22 Vertex Pharmaceuticals Incorporated Azaindole derivatives as CFTR modulators
US8802868B2 (en) 2010-03-25 2014-08-12 Vertex Pharmaceuticals Incorporated Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
MX2012012204A (es) 2010-04-22 2012-12-05 Vertex Pharma Proceso para producir compuestos de cicloalquilcarboxamido-indol.
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen
WO2012135027A2 (en) * 2011-03-25 2012-10-04 The Research Foundation Of State University Of New York Thiolactone antibiotics
HK1209318A1 (en) 2012-07-16 2016-04-01 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions of (r)-1-(2,2-diflurorbenzo[d][1,3]dioxol-5-yl)-n-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1h-indol-5-yl) cyclopropanecarboxamide and administration thereof
DK3925607T3 (da) 2014-04-15 2023-08-21 Vertex Pharma Farmaceutiske sammensætninger til behandlingen af cystisk fibrosetransmembrankonduktansregulator-medierede sygdomme
CN115785079B (zh) * 2022-11-28 2024-02-13 沈阳药科大学 4-(1h-吲哚-5-基)氨基呋喃-2(5h)-酮类化合物及其制备和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2225465A1 (en) * 1995-08-02 1997-02-13 Newcastle University Ventures Limited Benzimidazole compounds
CO4970714A1 (es) 1997-09-05 2000-11-07 Boehringer Mannheim Gmbh Derivados ureido y tioureido de 4-amino-2(5h)-furanonas y 4-amino-2(5h) tiofenonas como agentes antitumorales
DE19814838C2 (de) 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
ATE330955T1 (de) * 1998-04-28 2006-07-15 Elbion Ag Indolderivate und deren verwendung als inhibitoren der phosphodiesterase 4.

Also Published As

Publication number Publication date
BR0016553A (pt) 2002-09-17
TR200201613T2 (tr) 2002-10-21
AU2170401A (en) 2001-07-09
AU776332B2 (en) 2004-09-02
NO323312B1 (no) 2007-03-12
ZA200204964B (en) 2004-01-29
CA2395205A1 (en) 2001-07-05
WO2001047916A1 (en) 2001-07-05
DE60022227D1 (de) 2005-09-29
HUP0203524A3 (en) 2008-01-28
NZ519689A (en) 2004-02-27
EP1244652B1 (en) 2005-08-24
PL356541A1 (en) 2004-06-28
US20030158153A1 (en) 2003-08-21
CN1413205A (zh) 2003-04-23
DE60022227T2 (de) 2006-06-22
ES2246918T3 (es) 2006-03-01
IT1315267B1 (it) 2003-02-03
KR20020063247A (ko) 2002-08-01
HUP0203524A2 (hu) 2003-03-28
ATE302772T1 (de) 2005-09-15
KR100795533B1 (ko) 2008-01-16
IL150329A (en) 2006-07-05
IL150329A0 (en) 2002-12-01
EA200200558A1 (ru) 2002-12-26
NO20022976L (no) 2002-06-20
JP2003519140A (ja) 2003-06-17
EP1244652A1 (en) 2002-10-02
MXPA02006217A (es) 2004-02-26
CN1250542C (zh) 2006-04-12
CZ20022170A3 (cs) 2002-09-11
US6753342B2 (en) 2004-06-22
SK285682B6 (sk) 2007-06-07
ITMI992693A0 (it) 1999-12-23
ITMI992693A1 (it) 2001-06-23
SK8962002A3 (en) 2002-11-06
EA004925B1 (ru) 2004-10-28

Similar Documents

Publication Publication Date Title
NO20022976D0 (no) 2-(1H-indol-3yl)-2-okso-acetamider med antitumoraktivitet
DE69918422D1 (de) Phthalazinone pde iii/iv hemmer
TR200000059T2 (tr) Piridin türevleri
ATE258930T1 (de) Dihydrobenzifurane
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
DE60005689D1 (de) Neue aminobenzophenone
SE9903290D0 (sv) Novel compounds
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate
DK1377574T3 (da) 6-phenylbenzonaphtyridiner
BG106937A (en) Novel indole derivatives
ATE286887T1 (de) Antibakterielle mittel
MA24197A1 (fr) Nouvelles fungarrestines
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
DE59901563D1 (de) N-substituierte azabicycloheptan-derivate, ihre herstellung und verwendung
ES2166710A1 (es) Nuevos compuestos heterociclicos con actividad antiinflamatoria.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees